Selected publications
-
A phase IIa study of afuresertib, an oral pan-AKT inhibitor, in patients with Langerhans cell histiocytosis.
Pediatric Blood and Cancer.
2017
Academic Article
GET IT
Times cited: 9 -
Polycythemia vera: An appraisal of the biology and management 10 years after the discovery of JAK2 V617F.
Journal of Clinical Oncology.
2015
Review
GET IT
Times cited: 29 -
Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease.
Blood.
2014
Review
GET IT
Times cited: 228 -
A self-assembling short oligonucleotide duplex suitable for pretargeting.
Nucleic Acid Therapeutics.
2013
Academic Article
GET IT
Times cited: 6 -
A multivalent DNA aptamer specific for the B-cell receptor on human lymphoma and leukemia.
Nucleic Acids Research.
2011
Academic Article
GET IT
Times cited: 108 -
Sequential cytarabine and α-particle immunotherapy with bismuth-213-lintuzumab (HuM195) for acute myeloid leukemia.
Clinical Cancer Research.
2010
Academic Article
GET IT
Times cited: 127 -
Efficacy of the JAK2 inhibitor INCB16562 in a murine model of MPLW515L-induced thrombocytosis and myelofibrosis.
Blood.
2010
Academic Article
GET IT
Times cited: 56 -
Sequential therapy with fludarabine, high-dose cyclophosphamide, and rituximab in previously untreated patients with chronic lymphocytic leukemia produces high-quality responses: Molecular remissions predict for durable complete responses.
Journal of Clinical Oncology.
2009
Academic Article
GET IT
Times cited: 59 -
Myeloid growth factors.
JNCCN Journal of the National Comprehensive Cancer Network.
2009
Conference Paper
GET IT
Times cited: 37 -
Vitamin C antagonizes the cytotoxic effects of antineoplastic drugs.
Cancer Research.
2008
Academic Article
GET IT
Times cited: 143 -
Multiple erythematous eroded patches and papules on the scalp.
Archives of Dermatology.
2008
Academic Article
GET IT
Times cited: 3 -
Myeloid growth factors: Clinical practice guidelines in oncology™.
JNCCN Journal of the National Comprehensive Cancer Network.
2007
Review
GET IT
Times cited: 53 -
Clinical experience with intravenous and oral formulations of the novel histone deacetylase inhibitor suberoylanilide hydroxamic acid in patients with advanced hematologic malignancies.
Journal of Clinical Oncology.
2006
Academic Article
GET IT
Times cited: 345 -
Human mitochondrial peptide deformylase, a new anticancer target of actinonin-based antibiotics.
Journal of Clinical Investigation.
2004
Academic Article
GET IT
Times cited: 86 -
Refractory aspergillus pneumonia in patients with acute leukemia: Successful therapy with combination caspofungin and liposomal amphotericin.
Cancer.
2003
Academic Article
GET IT
Times cited: 227 -
Expression of granulocyte-macrophage colony-stimulating factor receptors in human prostate cancer.
Blood.
1998
Academic Article
GET IT
Times cited: 38